ReviewCanadian journal of anaesthesia = Journal canadien d'anesthesie2026
High-flow nasal oxygen in anesthesiology practice.
Review in Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeHypoxemia is an important complication of general anesthesia and procedural sedation and is associated with cardiopulmonary complications, increased hospital length of stay, and increased mortality. Through this Continuing Professional Development module, we aim to guide anesthesiologists in the safe use of high-flow nasal oxygen (HFNO). It examines the potential advantages and limitations of HFNO across the spectrum of anesthesiology practice, from procedural sedation to airway management, highlighting its role in enhancing patient safety. PRINCIPAL
findingsHigh-flow nasal oxygen is a noninvasive respiratory support modality capable of delivering high flow rates and oxygen concentrations to patients during spontaneous breathing and apneic periods. Its efficacy depends on airway patency and on whether a patient's mouth is open or closed. Although HFNO can improve oxygenation and potentially prolong safe apnea times during airway management, clinicians must be aware of risks, such as progressive hypercapnia during prolonged apneic periods.
conclusionsKey advantages of HFNO include ease of application, the delivery of high inspired oxygen fractions and flow rates, and the potential generation of continuous positive airway pressure. For specific patient populations, HFNO can enhance respiratory support and safety throughout diverse perioperative situations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.